Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-04, Stock:NVS, The news for the past five days is as follows:
2020-10-28: NEWS1: The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts.NEWS2: Novartis Strikes Deal To Commercialize Molecular Partners' COVID-19 Drug Candidates.NEWS3: Molecular Partners jumps after Novartis deal for potential COVID-19 drugs.NEWS4: Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19.
2020-10-29: NEWS1: Incyte (INCY) to Post Q3 Earnings: Will Jakafi Drive Results?.NEWS2: Novartis Snaps Up Vedero Bio In $280M Deal; Street Says Buy.NEWS3: The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal.NEWS4: Novartis buys Vedere Bio, whose founders helped blind mice see.NEWS5: CORRECTED-Novartis buys Vedere Bio to boost gene therapy.
2020-10-30: NEWS1: Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study.NEWS2: Pharmaceutical Industry Leaders Target Cutting-Edge MS Treatments That Once Were 'Fantasy'.NEWS3: Novartis expands Kymriah® manufacturing footprint with first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia.
2020-11-02: NEWS1: Novartis Expands Presence in Gene Therapy With Acquisition.NEWS2: Top Analyst Reports for PayPal, Comcast & Novartis.NEWS3: Analyst Report: Novartis AG.NEWS4: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, Pfizer, Novartis, AstraZeneca and J&J.NEWS5: Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention.
2020-11-03: NEWS1: The Zacks Analyst Blog Highlights: PayPal, Comcast, Novartis, BlackRock and FedEx.

Answer: Rise